Wendy Halpern

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

Kevin P. Baker, Bryan Edwards, Sarah Main et al. · Arthritis & Rheumatism · 2003 · 470 citations

Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody With Agonist Activity to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor-1

Anthony W. Tolcher, Monica Mita, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 311 citations · Full text

Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers

Ruth Plummer, Gerhardt Attard, Simon Pacey et al. · Clinical Cancer Research · 2007 · 243 citations · Full text

Use of Severity Grades to Characterize Histopathologic Changes

Kenneth A. Schafer, John Eighmy, James Fikes et al. · Toxicologic Pathology · 2018 · 201 citations

Hepatology, Oncopathology, Clinical Endpoint +12

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

F. Anthony Greco, Philip Bonomi, Jeffrey Crawford et al. · Lung Cancer · 2008 · 163 citations

Cancer Immunosurveillance, Medicine, Trail Receptor-1 +7